Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole switch for smoking in schizophrenia
NCT00167817Phase 4Completed
- Sponsor
- Veterans Medical Research Foundation
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aripiprazole in schizophrenia, sponsored by Veterans Medical Research Foundation. Primary endpoints: Saliva cotinine at 8 weeks and Fagerstrom Test for Nicotine Dependence at 8 weeks. Started Jul 2003; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00167817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00167817.